principles of management

Last edited 06/2023 and last reviewed 06/2023

  • standard initial management of eczema includes:
    • the use of emollients and topical corticosteroids of appropriate potency to treat affected sites

    • topical calcineurin inhibitors (including tacrolimus and pimecrolimus) are licensed for use in adults and children two years of age and older as second-line treatments for moderate to severe eczema that has not been controlled by topical corticosteroids, when there is serious risk of important adverse eIects from further topical corticosteroid use (particularly irreversible skin atrophy)

  • systemic immunosuppressive treatments are reserved for the treatment of more severe cases of eczema that have been inadequately controlled with topical treatments (such as topical corticosteroids and topical calcineurin inhibitors)

Reference:

Related pages:

first-line therapy

second-line therapy